SII CEO Adar Poonawalla said that SII has stopped production of Kovishield vaccine from December 2021 and out of the total stock available at that time, about 100 million doses have expired.
PUNE: Serum Institute of India (SII) Chief Executive Officer (CEO) Adar Poonawalla said on Thursday that SII has stopped production of Kovishield vaccine from December 2021 and out of the total stock available at that time, about 100 million doses have been used. period has expired. Talking to reporters on the sidelines of the Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) in Pune, Poonawalla said there is no demand for a precautionary dose as people are fed up with the pandemic and have become apathetic about vaccination.
When asked about the updated information related to Kovishield vaccine, Poonawalla said, ‘We have stopped production (of Kovishield) from December 2021. We had a stock of crores of vaccines at that time, out of which 100 million doses have expired. He said that it is permissible to apply mixed doses of SII vaccines.
Poonawalla said, ‘Now Kovovax can be approved in the next two weeks. So I think they will probably allow mixed doses of preventive vaccines and they should. If the WHO (World Health Organisation) approves it, then probably the Indian regulator will also give permission and it should also do so.
“However, at present, there is no demand for a precautionary dose. There is generally indifference to the precautionary dosages. People are fed up with Kovid-19 and vaccines. To be honest, I am fed up with it too. We are all fed up.
For Movie & TV show Reviews and Ratings, Bollywood, Tollywood and Hollywood News, Upcomming Movies, Indian TV Shows/Serials info, TV TRP/BARC Ratings and more!